The Biobank Ireland Symposium 2024 took place on 24 October at the Herbert Park Hotel in Dublin. The event highlighted the role of biobanking in the development of healthcare and the innovation of new treatments and diagnostic systems. Led by renowned broadcaster Áine Lawlor, the symposium gathered a diverse range of biobanking experts, researchers, policymakers, and healthcare professionals from Ireland and beyond. The event provided a platform for discussing Ireland’s contributions to biobanking, with a special focus on how this field supports cutting-edge research, enhances disease prevention strategies, and contributes to the development of new treatments.
The symposium’s keynote presentations featured notable scientists, with Sean Hynes explaining biobanking fundamentals, followed by Richard Flavin on Biobank Ireland’s contributions, and Alison Parry-Jones discussing global biobanking trends, providing insights into the development of biobanking standards and the importance of ethical considerations in biobank operations, while Farrell discussed the significance of biobanks in supporting longitudinal research and improving public health outcomes. Professor Michael Farrell discussed advancements in biobank management, global collaboration, and the integration of patient perspectives in biobanking.
Josephine Brady provided a unique view on literature’s role in cancer responses, whilst Eddie Mullin emphasised the patient perspective. The programme resumed with a lively panel discussion, centred on the impact of biobanks on both public health and personalised medicine. Experts discussed how biobanks provide essential biological samples that enable researchers to understand complex diseases and tailor treatments to individual patients. Michael Farrell’s talk on using archival samples highlighted biobanking’s value in public interest research, while John O’Leary emphasised biobanking as essential for medical advancements. Additionally, patient representatives shared their perspectives, emphasising the importance of biobanking in developing treatments for rare and complex diseases.
Networking sessions allowed attendees to exchange ideas and explore collaborations. Participants discussed the potential for Ireland to strengthen its position in global biobanking initiatives and the need for more funding and policy support to maximise the country’s biobanking impact. The symposium highlighted the role of biobanking in advancing precision medicine and its potential to transform patient care by enabling better-targeted therapies. The symposium closed with open discussions and concluding remarks from Eoin Gaffney.
In summary, the Biobank Ireland Symposium 2024 underscored the growing importance of biobanking in the medical and research communities. The event served as a vital forum for discussing the future of biobanking in Ireland and its potential contributions to global health. By bringing together leading experts, the symposium fostered critical dialogue on how to leverage biobank resources for impactful research, illustrating the ongoing commitment to advancing healthcare through innovation and collaboration.
Back Row left to Right – Ciaran Flanagan (Biobank Ireland Trust), Michael Farrell (RCSI Retd), Professor Richard Flavin (St James Hospital), Eddie Mullin (Biobank Ireland Trust)
Front Row Left to Right – Josephine Brady (Author), Brendan Nagle, Aine Lalor (RTE), Professor Eoin Gaffney (Biobank Ireland Trust), Professor John O’Leary (TCD) , Professor Sean Hynes (NUIG)
